Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Sep 21, 2020

Omri Shor, CEO and co-founder, Medisafe talks about the different aspects of medication adherence and challenges faced by patients trying to maintain their drug therapy schedules. With an eye towards personalized medicine, Medisafe strives to build bridges and integrate healthcare services for patients to allow them to...


Sep 21, 2020

Omri Shor, CEO and co-founder, Medisafe talks about the different aspects of medication adherence and challenges faced by patients trying to maintain their drug therapy schedules. With an eye towards personalized medicine, Medisafe strives to build bridges and integrate healthcare services for patients to allow them to...


Aug 4, 2020

Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples.  The company's Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of...


Aug 4, 2020

Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples.  The company's Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of...


Jan 6, 2020

Dr. Nader Pourhassan, is Director, President, and CEO, CytoDyn, a late-stage biotechnology company developing leronlimab (PRO 140), a targeted therapy with the potential to treat multiple diseases.  Nader highlights CytoDyn's ongoing clinical trial evaluating leronlimab for metastatic triple negative breast cancer...